Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Identification of altered salivary microRNAs in Cavalier King Charles Spaniels affected by mitral valve disease at different ACVIM stages

Title: Identification of altered salivary microRNAs in Cavalier King Charles Spaniels affected by mitral valve disease at different ACVIM stages
Authors: Ghilardi, Sara; Salvi, Gaspare; Bagardi, Mara; Balbi, Ombretta; Balgera, Asia; Dadi, Yasmine; Romito, Giovanni; Polli, Michele; Arigoni, Maddalena; Calogero, Raffaele; Brambilla, Paola G.; Lecchi, Cristina
Contributors: S. Ghilardi; G. Salvi; M. Bagardi; O. Balbi; A. Balgera; Y. Dadi; G. Romito; M. Polli; M. Arigoni; R. Calogero; P.G. Brambilla; C. Lecchi
Publisher Information: Springer Nature Publishing Group
Publication Year: 2026
Collection: The University of Milan: Archivio Istituzionale della Ricerca (AIR)
Subject Terms: Biomarker; Cavalier King Charles Spaniel; Dog; Myxomatous mitral valve disease; Saliva; microRNA; Settore MVET-02/A - Patologia generale e anatomia patologica veterinaria; Settore MVET-04/B - Clinica medica veterinaria
Description: Myxomatous mitral valve disease (MMVD) in Cavalier King Charles Spaniels (CKCSs) can be diagnosed at a young age. Early and sensitive biomarkers related to the disease are currently lacking. MicroRNAs (miRNAs) are involved in the onset and progression of canine MMVD. This study aimed to profile the salivary miRNAs associated with MMVD severity in CKCSs and to identify their target genes. This was a pilot prospective, cross-sectional study. Saliva was collected from twenty-five CKCSs belonging to the American College of Veterinary Internal Medicine (ACVIM) stages A (n. 6), B1 (n. 13), and B2 (n. 6), and salivary miRNAs’ expression was profiled by Next Generation Sequencing. miRNAs’ target genes were identified using bioinformatic tools. Results showed that 25 miRNAs were differentially expressed (DE) between ACVIM A and B1 dogs; 35 DE-miRNAs were modulated in ACVIM B2 compared to B1 CKCSs; 4 miRNAs were up-regulated in ACVIM stage B1 patients compared to both ACVIM stages A and B2. These findings confirm that salivary miRNAs can be successfully quantified in CKCSs and that their expression differs across MMVD severity groups. The DE-miRNAs were associated with signalling pathways related to cellular metabolism, survival, and early inflammatory remodeling. Given the exploratory and cross-sectional design, these miRNAs should be considered candidate, non-invasive indicators associated with disease severity rather than established biomarkers. Further longitudinal and validation studies are needed to assess their diagnostic potential.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/41720889; firstpage:1; lastpage:42; numberofpages:42; journal:SCIENTIFIC REPORTS; https://hdl.handle.net/2434/1221332
DOI: 10.1038/s41598-026-38660-y
Availability: https://hdl.handle.net/2434/1221332; https://doi.org/10.1038/s41598-026-38660-y
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number: edsbas.43DB429F
Database: BASE